Christine Robinson, Carly Baehr, Shirdi E. Schmiel, Claudia Accetturo, Daniel L. Mueller, & Marco Pravetoni. (2019). Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders. Taylor & Francis Group.
Chicago Style (17th ed.) CitationChristine Robinson, Carly Baehr, Shirdi E. Schmiel, Claudia Accetturo, Daniel L. Mueller, and Marco Pravetoni. Alum Adjuvant Is More Effective than MF59 at Prompting Early Germinal Center Formation in Response to Peptide-protein Conjugates and Enhancing Efficacy of a Vaccine Against Opioid Use Disorders. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationChristine Robinson, et al. Alum Adjuvant Is More Effective than MF59 at Prompting Early Germinal Center Formation in Response to Peptide-protein Conjugates and Enhancing Efficacy of a Vaccine Against Opioid Use Disorders. Taylor & Francis Group, 2019.